Here, we show that the m6A methyltransferase complex METTL3/METTL14 is upregulated in primary CML samples, and that its downregulation strongly affects proliferation of both primary CML and imatinib -sensitive and -resistant CML cell lines. The gene discussed is METTL3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.